Chimeric Therapeutics Ltd (CHM) — Net Asset Momentum
Chimeric Therapeutics Ltd (CHM) recorded a net asset momentum of -20.1% as of June 2025, with net assets of AU$1.97 Million AUD. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See Chimeric Therapeutics Ltd (CHM) liquidity interval to measure how many days the company can operate on defensive assets alone.
YoY Momentum
Current Net Assets
Years of Data
Country
Chimeric Therapeutics Ltd Net Asset Momentum (2020–2025)
This chart tracks Chimeric Therapeutics Ltd's year-over-year net asset growth across 6 annual reporting periods from 2020 to 2025. The most recent momentum reading is -20.1%, with net assets of AU$1.97 Million AUD as of June 2025. Read CHM current and long-term liabilities for a breakdown of total debt and financial obligations.
Annual Net Asset History for Chimeric Therapeutics Ltd (2020–2025)
The table below shows the complete annual net asset history for Chimeric Therapeutics Ltd from 2020 to 2025, covering 6 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and broader valuation context, see Chimeric Therapeutics Ltd (CHM) total market value.
| Year | Net Assets (AUD) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | AU$1.97 Million | AU$21.57 Million | AU$19.60 Million | ▼ -20.1% |
| 2024 | AU$2.47 Million | AU$15.27 Million | AU$12.80 Million | ▼ -56.4% |
| 2023 | AU$5.66 Million | AU$22.38 Million | AU$16.71 Million | ▼ -78.0% |
| 2022 | AU$25.71 Million | AU$34.88 Million | AU$9.17 Million | ▲ +2.3% |
| 2021 | AU$25.13 Million | AU$36.50 Million | AU$11.37 Million | ▲ +39423.8% |
| 2020 | AU$-63.91K | AU$100.00 | AU$64.01K | — |